A joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt

Molecular surveillance of multidrug-resistant tuberculosis (MDR-TB) using 24-loci MIRU-VNTR in the European Union suggests the occurrence of international transmission. In early 2014, Austria detected a molecular MDR-TB cluster of five isolates. Links to Romania and Germany prompted the three countries to investigate possible cross-border MDR-TB transmission jointly. We searched genotyping databases, genotyped additional isolates from Romania, used whole genome sequencing (WGS) to infer putative transmission links, and investigated pairwise epidemiological links and patient mobility. Ten isolates from 10 patients shared the same 24-loci MIRU-VNTR pattern. Within this cluster, WGS defined two subgroups of four patients each. The first comprised an MDR-TB patient from Romania who had sought medical care in Austria and two patients from Austria. The second comprised patients, two of them epidemiologically linked, who lived in three different countries but had the same city of provenance in Romania. Our findings strongly suggested that the two cases in Austrian citizens resulted from a newly introduced MDR-TB strain, followed by domestic transmission. For the other cases, transmission probably occurred in the same city of provenance. To prevent further MDR-TB transmission, we need to ensure universal access to early and adequate therapy and collaborate closely in tuberculosis care beyond administrative borders.

[1]  F. Cobelens,et al.  Tuberculosis outbreaks predicted by characteristics of first patients in a DNA fingerprint cluster. , 2008, American journal of respiratory and critical care medicine.

[2]  S. Niemann,et al.  embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. , 2010, The Journal of antimicrobial chemotherapy.

[3]  P. Sonnenberg,et al.  Prospective evaluation of a complex public health intervention: lessons from an initial and follow-up cross-sectional survey of the tuberculosis strain typing service in England , 2014, BMC Public Health.

[4]  Steven J. M. Jones,et al.  Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. , 2011, The New England journal of medicine.

[5]  V. Fofanov,et al.  Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread. , 2015, The Journal of infectious diseases.

[6]  Daniel J. Wilson,et al.  Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study , 2013, The Lancet. Infectious diseases.

[7]  L. Fiebig,et al.  Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference? , 2016, Thorax.

[8]  R. Siezen,et al.  The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[9]  J. Oeltmann,et al.  Using tuberculosis patient characteristics to predict future cases with matching genotype results. , 2014, Public health action.

[10]  G. Dougan,et al.  Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology , 2012, PLoS pathogens.

[11]  Stefan Niemann,et al.  Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase , 2011, Nature Genetics.

[12]  Nader Pourmand,et al.  Use of Whole Genome Sequencing to Determine the Microevolution of Mycobacterium tuberculosis during an Outbreak , 2013, PloS one.

[13]  F. Dafae,et al.  Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting , 2012, BMC Microbiology.

[14]  V. Sintchenko,et al.  Added value of whole-genome sequencing for management of highly drug-resistant TB , 2014, The Journal of antimicrobial chemotherapy.

[15]  D van Soolingen,et al.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.

[16]  Timothy Brown,et al.  Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing. , 2014, The Lancet. Infectious diseases.

[17]  Phelim Bradley,et al.  Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study , 2015, The Lancet. Infectious diseases.

[18]  S. Althomsons,et al.  Using Routinely Reported Tuberculosis Genotyping and Surveillance Data to Predict Tuberculosis Outbreaks , 2012, PloS one.

[19]  Lisa J. Murray,et al.  Genomic Diversity among Drug Sensitive and Multidrug Resistant Isolates of Mycobacterium tuberculosis with Identical DNA Fingerprints , 2009, PloS one.

[20]  A. Khomenko,et al.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. , 1969, Bulletin of the World Health Organization.

[21]  D. van Soolingen,et al.  Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  Jens Stoye,et al.  Exact and complete short-read alignment to microbial genomes using Graphics Processing Unit programming , 2011, Bioinform..

[23]  W. Haas,et al.  [New recommendations for contact tracing in tuberculosis]. , 2011, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[24]  Laura Pérez-Lago,et al.  Whole genome sequencing analysis of intrapatient microevolution in Mycobacterium tuberculosis: potential impact on the inference of tuberculosis transmission. , 2014, The Journal of infectious diseases.

[25]  P. Mcelroy,et al.  Which patients' factors predict the rate of growth of Mycobacterium tuberculosis clusters in an urban community? , 2006, American journal of epidemiology.

[26]  M. Egger,et al.  Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing. , 2015, The Journal of infectious diseases.

[27]  Stefan Niemann,et al.  Whole-Genome-Based Mycobacterium tuberculosis Surveillance: a Standardized, Portable, and Expandable Approach , 2014, Journal of Clinical Microbiology.

[28]  Stefan Niemann,et al.  Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes , 2011 .

[29]  E. Rubin,et al.  The folate pathway is a target for resistance to the drug para‐aminosalicylic acid (PAS) in mycobacteria , 2004, Molecular microbiology.

[30]  T. Walker,et al.  Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  H. Soini,et al.  katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients , 1996, Antimicrobial agents and chemotherapy.

[32]  R. Siezen,et al.  High-Resolution Typing by Integration of Genome Sequencing Data in a Large Tuberculosis Cluster , 2010, Journal of Clinical Microbiology.

[33]  Stefan Niemann,et al.  Whole Genome Sequencing versus Traditional Genotyping for Investigation of a Mycobacterium tuberculosis Outbreak: A Longitudinal Molecular Epidemiological Study , 2013, PLoS medicine.

[34]  L. Bekker,et al.  Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Tracy L. Dalton,et al.  Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis , 2011, Antimicrobial Agents and Chemotherapy.

[36]  A. Sandgren,et al.  Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review , 2013, European Respiratory Journal.

[37]  A. Sandgren,et al.  Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement , 2012, European Respiratory Journal.

[38]  D. van Soolingen,et al.  Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011. , 2014 .

[39]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[40]  S. Niemann,et al.  Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study , 2014, mBio.